Correlation Between Viemed Healthcare and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viemed Healthcare and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viemed Healthcare and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viemed Healthcare and Spyre Therapeutics, you can compare the effects of market volatilities on Viemed Healthcare and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viemed Healthcare with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viemed Healthcare and Spyre Therapeutics.

Diversification Opportunities for Viemed Healthcare and Spyre Therapeutics

ViemedSpyreDiversified AwayViemedSpyreDiversified Away100%
0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viemed and Spyre is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Viemed Healthcare and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Viemed Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viemed Healthcare are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Viemed Healthcare i.e., Viemed Healthcare and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Viemed Healthcare and Spyre Therapeutics

Considering the 90-day investment horizon Viemed Healthcare is expected to generate 0.5 times more return on investment than Spyre Therapeutics. However, Viemed Healthcare is 2.01 times less risky than Spyre Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  848.00  in Viemed Healthcare on October 5, 2024 and sell it today you would lose (39.00) from holding Viemed Healthcare or give up 4.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Viemed Healthcare  vs.  Spyre Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15OctNovDec -20-100102030
JavaScript chart by amCharts 3.21.15VMD SYRE
       Timeline  
Viemed Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viemed Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Viemed Healthcare is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
JavaScript chart by amCharts 3.21.15NovDecJanDecJan88.599.5
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
JavaScript chart by amCharts 3.21.15NovDecJanDecJan25303540

Viemed Healthcare and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-3.09-2.32-1.54-0.76-0.01290.731.482.232.983.74 0.040.060.080.10
JavaScript chart by amCharts 3.21.15VMD SYRE
       Returns  

Pair Trading with Viemed Healthcare and Spyre Therapeutics

The main advantage of trading using opposite Viemed Healthcare and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viemed Healthcare position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Viemed Healthcare and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing